URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Robert Asbury

Concepts (160)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Antineoplastic Agents
24
1982
598
2.850
Why?
Imides
6
1993
7
1.690
Why?
Isoquinolines
6
1993
57
1.670
Why?
Thiadiazoles
7
1986
13
1.310
Why?
Uterine Neoplasms
5
1990
103
1.210
Why?
Antineoplastic Combined Chemotherapy Protocols
13
1985
409
0.840
Why?
Carcinoma
5
1989
188
0.790
Why?
Uterine Cervical Neoplasms
4
1987
125
0.790
Why?
Endometrial Neoplasms
3
1996
36
0.790
Why?
Colonic Neoplasms
6
1985
122
0.710
Why?
Carcinoma, Squamous Cell
4
1987
230
0.650
Why?
Neoplasm Recurrence, Local
5
1989
272
0.640
Why?
Lung Neoplasms
10
1983
422
0.620
Why?
Mixed Tumor, Mesodermal
2
1996
2
0.590
Why?
Leiomyosarcoma
2
1995
18
0.560
Why?
Adenocarcinoma
8
1985
431
0.500
Why?
Paclitaxel
5
1995
56
0.490
Why?
Middle Aged
34
1980
9461
0.480
Why?
Carcinoma, Non-Small-Cell Lung
5
1994
66
0.470
Why?
Aged
28
1984
6986
0.450
Why?
Etoposide
9
1983
73
0.440
Why?
Ovarian Neoplasms
4
1984
105
0.430
Why?
Goserelin
1
2002
5
0.430
Why?
Naphthalimides
6
1993
9
0.430
Why?
Female
40
1981
19061
0.410
Why?
Antineoplastic Agents, Hormonal
1
2002
44
0.410
Why?
Topotecan
1
2000
4
0.350
Why?
Humans
46
1980
35000
0.330
Why?
Adult
24
1984
10906
0.330
Why?
Esophageal Neoplasms
1
2000
76
0.320
Why?
Drug Administration Schedule
10
1984
362
0.290
Why?
Remission Induction
8
1989
155
0.280
Why?
Rectal Neoplasms
3
1985
82
0.270
Why?
Breast Neoplasms
8
1981
660
0.260
Why?
Neoplasm Metastasis
7
1981
219
0.260
Why?
Antineoplastic Agents, Phytogenic
4
1996
38
0.250
Why?
Drug Evaluation
9
1984
98
0.240
Why?
Carboplatin
6
1989
29
0.220
Why?
Pancreatic Neoplasms
1
1994
85
0.220
Why?
Survival Analysis
5
1994
575
0.190
Why?
Cisplatin
4
1986
93
0.190
Why?
Spiro Compounds
3
1988
4
0.190
Why?
Ifosfamide
5
1994
8
0.180
Why?
Fluorouracil
3
1986
77
0.180
Why?
Organometallic Compounds
3
1988
71
0.180
Why?
Aged, 80 and over
5
1996
2423
0.180
Why?
Infusions, Intravenous
4
1987
139
0.170
Why?
Organoplatinum Compounds
1
1989
6
0.170
Why?
Male
22
1980
18870
0.170
Why?
Stomach Neoplasms
2
1999
34
0.160
Why?
Mitoxantrone
4
1984
20
0.160
Why?
Mitomycins
2
1985
17
0.160
Why?
Neoplasm Staging
4
1996
326
0.150
Why?
Carcinoma, Small Cell
2
1983
33
0.150
Why?
Aclarubicin
2
1994
5
0.150
Why?
Folic Acid
1
1987
21
0.140
Why?
Aminoglutethimide
2
1981
6
0.140
Why?
Methotrexate
1
1985
73
0.120
Why?
Neoplasms
3
1992
701
0.120
Why?
Leukopenia
4
1984
24
0.110
Why?
Podophyllotoxin
1
1983
10
0.110
Why?
Allopurinol
2
1987
10
0.110
Why?
Hematologic Diseases
3
1985
40
0.100
Why?
Thrombocytopenia
3
1989
71
0.100
Why?
Budd-Chiari Syndrome
1
1980
9
0.090
Why?
Dacarbazine
1
1980
17
0.090
Why?
Drug-Induced Liver Injury
1
1980
35
0.090
Why?
Nausea
3
1981
153
0.090
Why?
Trimetrexate
1
1999
1
0.090
Why?
Antimetabolites, Antineoplastic
1
1999
38
0.080
Why?
Harringtonines
1
1999
2
0.080
Why?
Hydroxyurea
1
1999
14
0.080
Why?
Interferon-beta
1
1999
60
0.080
Why?
Vomiting
3
1982
114
0.080
Why?
Survival Rate
3
1991
584
0.080
Why?
Interleukin-2
1
1999
198
0.080
Why?
Sarcoma
2
1995
59
0.080
Why?
Colorectal Neoplasms
1
1999
138
0.070
Why?
Pilot Projects
4
1986
426
0.070
Why?
Gout Suppressants
1
1996
7
0.070
Why?
Lymphoma
2
1990
151
0.070
Why?
Radiation-Sensitizing Agents
1
1996
72
0.070
Why?
Antineoplastic Agents, Alkylating
1
1996
38
0.070
Why?
Uric Acid
1
1996
49
0.070
Why?
Mitomycin
2
1985
18
0.060
Why?
Carcinoma, Adenoid Cystic
1
1995
10
0.060
Why?
Mesna
1
1994
2
0.060
Why?
Head and Neck Neoplasms
1
1995
78
0.060
Why?
Pelvic Neoplasms
1
1994
14
0.060
Why?
Treatment Outcome
3
1994
2487
0.060
Why?
Chemotherapy, Adjuvant
1
1994
85
0.060
Why?
Vincristine
3
1986
57
0.060
Why?
Adjuvants, Immunologic
1
1994
118
0.050
Why?
Diarrhea
2
1987
61
0.050
Why?
Oncologic Nursing
1
1992
8
0.050
Why?
Psychology, Clinical
1
1992
5
0.050
Why?
Drug Therapy
1
1992
45
0.050
Why?
Medical Oncology
1
1992
40
0.050
Why?
Behavior Therapy
1
1992
95
0.050
Why?
Melphalan
1
1990
27
0.040
Why?
Multicenter Studies as Topic
1
1990
126
0.040
Why?
Anemia
1
1990
76
0.040
Why?
Random Allocation
1
1989
245
0.040
Why?
Leukemia, Myelomonocytic, Acute
1
1988
11
0.040
Why?
Hydrocortisone
1
1989
131
0.040
Why?
Bone Marrow Transplantation
1
1990
189
0.040
Why?
Catheterization, Central Venous
1
1988
59
0.040
Why?
Stomach
1
1988
70
0.040
Why?
Intestine, Small
1
1988
110
0.040
Why?
Prognosis
1
1989
1030
0.030
Why?
Skin Neoplasms
1
1988
225
0.030
Why?
Injections, Intravenous
2
1990
125
0.030
Why?
Anthraquinones
1
1984
7
0.030
Why?
Liver Neoplasms
1
1986
149
0.030
Why?
Melanoma
2
1980
133
0.030
Why?
Drug Therapy, Combination
2
1989
375
0.030
Why?
Prostatic Neoplasms
1
1989
548
0.030
Why?
Drug Resistance
1
1983
97
0.030
Why?
Sleep Stages
1
1981
21
0.020
Why?
Hormones
1
1981
63
0.020
Why?
Combined Modality Therapy
2
1986
459
0.020
Why?
Thiotepa
2
1989
6
0.020
Why?
Mitolactol
2
1989
6
0.020
Why?
Vinblastine
2
1989
27
0.020
Why?
Necrosis
1
1980
99
0.020
Why?
Dexamethasone
1
1981
176
0.020
Why?
Doxorubicin
2
1989
102
0.020
Why?
Antibiotics, Antineoplastic
1
1999
51
0.020
Why?
Drug Resistance, Neoplasm
1
1999
54
0.020
Why?
Safety
1
1999
99
0.020
Why?
Salvage Therapy
1
1999
56
0.020
Why?
Pain
1
1981
363
0.020
Why?
Disease Progression
1
1999
496
0.020
Why?
Ascitic Fluid
1
1996
21
0.020
Why?
Alopecia
1
1996
22
0.020
Why?
Treatment Failure
1
1996
125
0.020
Why?
Granulocyte Colony-Stimulating Factor
1
1996
42
0.020
Why?
Liver
1
1980
870
0.020
Why?
Fever
1
1996
106
0.020
Why?
Neutropenia
1
1996
61
0.020
Why?
Cohort Studies
1
1999
912
0.020
Why?
Follow-Up Studies
2
1986
1757
0.010
Why?
Kidney
1
1996
581
0.010
Why?
Retrospective Studies
1
1999
2167
0.010
Why?
Time Factors
2
1989
3047
0.010
Why?
Cyclophosphamide
1
1991
169
0.010
Why?
Biological Availability
1
1990
39
0.010
Why?
Carmustine
1
1990
35
0.010
Why?
Fluoxymesterone
1
1989
4
0.010
Why?
Randomized Controlled Trials as Topic
1
1992
400
0.010
Why?
Administration, Oral
1
1990
302
0.010
Why?
Hematoma
1
1988
38
0.010
Why?
Motilin
1
1988
3
0.010
Why?
Nervous System Diseases
1
1989
141
0.010
Why?
Periodicity
1
1988
40
0.010
Why?
Palliative Care
1
1989
151
0.010
Why?
Dogs
1
1988
465
0.010
Why?
Electrophysiology
1
1988
243
0.010
Why?
Behavior, Animal
1
1988
229
0.010
Why?
Animals
1
1988
15647
0.000
Why?

Visualizations


Asbury's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department